Immunocore presented two posters at CROI 2024
05 mars 2024 16h30 HE
|
Immunocore Holdings Limited
Immunocore presented two posters at CROI 2024 Preclinical data highlights importance of TCR biology in development of new HIV treatments (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. &...
Immunocore announces strategic priorities and pipeline expansion ahead of 42nd Annual J.P. Morgan Healthcare Conference presentation
05 janv. 2024 07h00 HE
|
Immunocore Holdings Limited
Immunocore announces strategic priorities and pipeline expansion ahead of 42nd Annual J.P. Morgan Healthcare Conference presentation Increasing commercial access to KIMMTRAK (tebentafusp-tebn)...
New Novotech Report Finds 1,000 HIV Clinical Trials Globally
28 déc. 2023 21h49 HE
|
Novotech
Novotech today released the latest 2023 global clinical trial landscape report on HIV, a condition now affecting more than 39 million people.
HOOKIPA Pharma Announces $21.25 Million Equity Investment from Gilead Sciences
21 déc. 2023 07h01 HE
|
HOOKIPA Pharma Inc.
Gilead purchased 15 million newly issued shares of common stock at a price of $1.4167 per shareFollowing the close of the transaction on December 20, 2023, Gilead holds 19.4% of HOOKIPA’s outstanding...
Theratechnologies annonce l’approbation par la FDA de l’administration par injection IV directe d’une durée de 90 secondes de la dose de charge de Trogarzoᴹᴰ
13 déc. 2023 07h30 HE
|
Theratechnologies
La mise à jour de la monographie signifie que les nouveaux patients à qui l’on prescrit TrogarzoMD n’ont plus besoin de commencer le traitement par une perfusion de 30 minutesL’injection IV directe...
Theratechnologies Announces FDA Approval of Trogarzo® 90-Second Intravenous (IV) Push Loading Dose
13 déc. 2023 07h30 HE
|
Theratechnologies
Updated label means new Trogarzo® patients no longer require initiation of treatment by 30-minute infusionComplete IV push method enables easier and more convenient administration of Trogarzo® for...
Coalition of Leading U.S. Companies Reveals Joint Progress to Combat HIV Epidemic on Eve of World AIDS Day
30 nov. 2023 10h19 HE
|
Health Action Alliance
Washington, D.C., Nov. 30, 2023 (GLOBE NEWSWIRE) -- As Congress debates potential deep cuts to federal funding for critical HIV programs on the eve of World AIDS Day, a growing number of leading...
bioLytical Laboratories Inc. Donates Tests to Help Boost International Testing Access Ahead of International Testing Week
22 nov. 2023 13h30 HE
|
bioLytical Laboratories Inc.
bioLytical Laboratories Inc. and NGO Coalition Plus Lead the Charge to Promote the Importance of Rapid Testing during International Testing Week
HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-500 for the Treatment of Human Immunodeficiency Virus
20 nov. 2023 07h01 HE
|
HOOKIPA Pharma Inc.
Novel arenaviral therapeutic vaccine, developed in collaboration with Gilead Sciences, Inc. (‘Gilead’), to be evaluated as a potential curative regimen for human immunodeficiency virus (HIV)Phase 1...
HOOKIPA Pharma Reports Third Quarter 2023 Financial Results and Recent Business Highlights
09 nov. 2023 07h01 HE
|
HOOKIPA Pharma Inc.
Reported positive preliminary Phase 2 data on additional patients for HB-200 in combination with pembrolizumab in the 1st-line setting for advanced HPV16+ head and neck cancer; data reinforce strong...